Concentra Group (CON) officer granted 40,000 RS; now owns 80,098
Concentra Group Holdings Parent, Inc. (CON) reported a Form 4 showing an equity award to an executive.
Rhea-AI Filing Summary
Concentra Group Holdings Parent, Inc. (CON) reported a Form 4 showing an equity award to an executive. On 11/04/2025, the officer received 40,000 shares of restricted stock at $0. The grant will vest in equal annual installments over four years. After this transaction, the reporting person beneficially owned 80,098 shares, held directly. The executive’s title is Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 40,000 shares
Grant/Award
1 txn
Insider
Rhine Michael D.
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 40,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 80,098 shares (Direct)
Footnotes (1)
- F1. Grant of restricted stock which will vest in equal annual installments over four years.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Concentra Group (CON) report on this Form 4?
An officer received 40,000 restricted shares on 11/04/2025 at $0, vesting over four years.
What is the vesting schedule for the restricted stock grant at CON?
The 40,000 restricted shares vest in equal annual installments over four years.
What is the officer’s role noted in the filing for CON?
The officer is Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine.
What type of security was involved in the CON insider transaction?
Common stock (restricted stock) was granted; no derivative securities were listed in Table II.
AI-generated analysis. How Rhea-AI works. Not financial advice.